NCT07340034

Brief Summary

This study contributes to the growing body of knowledge on rehabilitation strategies for post-stroke patients, specifically focusing on the efficacy of vibration therapy modalities. By comparing focal muscle vibration therapy and whole upper limb vibration therapy, the research aims to provide empirical evidence that can inform clinical practices and enhance rehabilitation outcomes. The findings are expected to clarify which modality is more effective in reducing spasticity and improving motor control, thereby guiding clinicians in selecting appropriate interventions tailored to individual patient needs, increasing chances of benefits, time management and useful for academic purpose. Furthermore, the study addresses a critical gap in the literature, facilitating further research and discussion on the mechanisms underlying vibration therapy's effects. Ultimately, this research aims to reduce spasticity and improve community outcomes by enhancing the quality of life for stroke survivors, enabling them to regain independence and participate more fully in daily activities by regaining the motor control functions. By contributing to both theoretical and practical frameworks, the study seeks to advance the field of neurorehabilitation and support informed decision-making among healthcare professionals.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
0mo left

Started Dec 2025

Shorter than P25 for not_applicable stroke

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Dec 2025May 2026

Study Start

First participant enrolled

December 20, 2025

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

January 5, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2026

Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

January 5, 2026

Last Update Submit

January 5, 2026

Conditions

Keywords

Whole upper limb vibrationFocal muscle vibrationUpper limb spasticityUpper Motor Control Functions

Outcome Measures

Primary Outcomes (2)

  • Fugl-Meyer assessment of upper limb (FMA-UE)

    The Fugl-Meyer Assessment-Upper Extremity (FMA-UE) is a commonly utilized tool for measuring motor impairment in stroke rehabilitation. The FMA-UE has demonstrated excellent test-retest and inter- and intra-rater reliability, and evidence for its content validity in acute and subacute populations have been widely reported. The UE section of the FMA consists of 33 items and is scored on a 3-point ordinal scale with 0 meaning cannot perform, 1 meaning can partially perform, and 2 meaning can perform fully. Scores are summed with a maximum potential score of 66 points.

    baseline, after 2 weeks and 4 weeks

  • Modified Ashworth scale (MAS)

    The Modified Ashworth Scale (MAS) is the most widely used clinical tool for measuring increased muscle tone or spasticity The MAS has demonstrated excellent test-retest and inter- and intra-rater reliability, The inter-rater reliability of the scale has been reported to vary significantly depending on the muscle group being assessed, the examiner's experience, and methodological inconsistencies in applying the scale. The scale is as follows: 0: No increase in muscle tone 1. Slight increase in muscle tone, with a catch and release or minimal resistance at the end of the range of motion when an affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested as a catch, followed by minimal resistance through the remainder (less than half) of the range of motion 2. A marked increase in muscle tone throughout most of the range of motion 3. Considerable increase in muscle tone, passive movement difficult 4. Affected part(s) rigid in flexion or extension

    baseline, after 4 weeks and 8 weeks

Study Arms (2)

Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation

EXPERIMENTAL

Group A will receive the Focal muscle vibration in the major group of muscle such as Elbow flexors and wrist flexors along with the conventional neurorehabilitation.

Other: Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation

Upper limb vibration through whole body vibrator along with conventional neurorehabilitation

ACTIVE COMPARATOR

Group B will receive the upper limb vibration which will include all muscles of effected limb along with the conventional neurorehabilitation.

Other: Upper limb vibration through whole body vibrator along with conventional neurorehabilitation

Interventions

Group A will receive the 30 minutes treatment protocol. Warm-up exercises for first 15 minutes with ROM and stretching exercises of upper extremity 15 minutes application of FMV All participants were instructed to sit back in a high, fixed chair without armrests, keeping their feet flat on the floor. The dominant shoulder was positioned slightly away from the trunk i.e. in slight abduction and the elbow was held at a 90° angle as part of the designated vibration position. After setting up, the researcher guided the participants to remain seated in the same position as it might affect the results and treatment. The participants then received the vibration in frequency of 30 Hz in both vertical and horizontal directions. Based on our review of prior clinical studies aimed at improving muscle spasticity we implemented vibration protocols with exposure times ranging from 30 to 60 seconds and rest intervals between 15 and 60 seconds. The analysis focused on seven muscle groups

Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation

Group B will receive the 30 minutes treatment protocol. Warm-up exercises for first 15 minutes with ROM and stretching exercises of upper extremity. Patients in the treatment group received upper limb vibration using the Power Plate vibration platform (Performance Health Systems, Power Plate Pro5, North America 2009). The patient was seated on a stool placed next to the whole-body vibration device; the elbow was positioned at 70-80 degrees flexion and wrist was positioned at dorsiflexion and upper limb vibration was applied through Whole body vibrator to the affected limb for two minutes. The WBV consisted of two sessions of 60 seconds of stimulation interrupted by a one-minute break between each session to prevent muscle fatigue. The amplitude of the vibration was 2 mm, and the frequency was 35-40 Hz. An experienced physical therapist supervised the WBV administration. The upper limb vibration treatment was performed 5 times a week for 8 weeks.

Upper limb vibration through whole body vibrator along with conventional neurorehabilitation

Eligibility Criteria

Age45 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Lu YH, Chen HJ, Liao CD, Chen PJ, Wang XM, Yu CH, Chen PY, Lin CH. Upper extremity function and disability recovery with vibration therapy after stroke: a systematic review and meta-analysis of RCTs. J Neuroeng Rehabil. 2024 Dec 21;21(1):221. doi: 10.1186/s12984-024-01515-6.

    PMID: 39707380BACKGROUND
  • Karnath HO. Pusher syndrome--a frequent but little-known disturbance of body orientation perception. J Neurol. 2007 Apr;254(4):415-24. doi: 10.1007/s00415-006-0341-6. Epub 2007 Mar 25.

    PMID: 17385082BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Yamna Mazhar Yamna, MS NMPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
outcome assessor will be blind about participants allocation; this will ensure that their evaluations are objective and not influenced by knowledge of which treatment group participants belong to. Participants in both groups will be masked to the treatment of the other group by scheduling their sessions at different times
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will use a parallel-group design, with participants randomly allocated into two intervention groups. Group A (Focused Muscle Vibration - FMV) 30-minute session: 15 min upper-extremity ROM/stretching + 15 min FMV. FMV delivered at 30 Hz while seated (shoulder slightly abducted, elbow at 90°). Vibration applied in 60-s bouts with 60-s rest. Target muscles: biceps, triceps, anterior deltoid, FDS, FCR, ECR, ECU. Frequency: 5 days/week for 8 weeks. Group B (Upper Limb Vibration ULV) 30-minute session: 15 min ROM/stretching + ULV using Power Plate Pro5. Seated position with elbow 70-80° flexion and wrist dorsiflexed. ULV applied in 2 × 60-s bouts, 1-min rest, amplitude 2 mm, frequency 35-40 Hz. Frequency: 5 days/week for 8 weeks. Participants will be randomly allocated into two parallel groups to ensure an unbiased comparison, with each group receiving its specific intervention protocol throughout the study period without crossover to the other groups intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2026

First Posted

January 14, 2026

Study Start

December 20, 2025

Primary Completion (Estimated)

May 20, 2026

Study Completion (Estimated)

May 20, 2026

Last Updated

January 14, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share